Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03706755
Other study ID # Norepinephrine
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date May 3, 2018
Est. completion date October 1, 2018

Study information

Verified date October 2018
Source University Tunis El Manar
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to determine the more effective intravenous bolus of norepinephrine for maintaining blood pressure during a spinal anesthesia for a cesarean delivery with the fewer side effects. Low blood pressure has been shown to decrease uterine perfusion and foetal outcomes during cesarean delivery under spinal anesthesia. For elective or semi-urgent cesarean delivery, all participants will receive spinal anesthesia with a local anesthetic and either sufentanil or fentanyl. This study plans to enroll 124 pregnant women. Patients will be randomly assigned according to a computer generated system to be in one of two groups.


Description:

This study will be a prospective, randomized, active treatment controlled trial.

After written and informed consent, the study participants will be randomly assigned using a computer generated table to 1 of 2 treatment groups prior to cesarean delivery.

Group A will receive an intravenous bolus of 1mcg/Kg of norepinephrine bitartrate to maintain systolic blood pressure (SBP) within 80-120% of baseline before the spinal anesthesia.

Group B will receive an intravenous bolus of 0.5mcg/kg of norepinephrine bitartrate to maintain systolic blood pressure (SBP) within 80-120% of baseline before the spinal anesthesia.

Patients will be admitted to holding area. Baseline arterial blood pressure and heart rate will be measured in supine position, with left uterine displacement. Baseline blood pressure will be calculated as the mean of three consecutive SBP measurements taken 3 minutes apart. 500 mL of Lactated Ringers solution will be administered immediately after induction of spinal anesthesia at the outflow rate of 100ml per hour.

The primary endpoints are:

the timing of the first maternal hypotension before delivery (defined as a decrease of SBP >20% of baseline and/or PAS<100mmHg) the delta PAS and delta PAM before delivery ( difference between basline and the lowest systolic and mean blood pressure respectively)

The secondary endpoints are:

Incidence of hypotension,norepinephrine consumption (mean dose of Norepinephrine to maintain blood pressure between 80 and 100 % of baseline values after the primary preventive bolus), nausea and vomiting will be recorded whenever present during the surgical procedure as well as reactive hypertension (defined as a rise of SBP >20% of baseline or SBP>140mmHg) and arrhythmia. Bradycardia (HR less than 50 BPM) will be treated with Atropine 0.5mg IV. Fetal cord blood analysis will be done immediately after delivery in order to determine the pH value ( ie : logarithm of the blood concentration of hydrogen ions H+)in each group

Study participants will receive a standard spinal anesthetic consisting of 0.5% hyperbaric bupivacaine (2 mL) with either sufentanil (5 mcg) or fentanyl (50 mcg) at L3-4 or L4-5. Prior to surgical incision, the spinal sensory level will be tested to the bilateral T6-T4 dermatomal level. The patients will be positioned supine with a wedge placed under the right hip to avoid aortocaval compression. Both the patient and the researcher's assistant (who will collect data) will be blinded as to the administered Norepinephrine bolus A or B.

When PAS<80% of baseline or < 100 mmHg a bolus of Norepinephrine will be administrated(half dose A or B).

The study will end when cesarean section is completed and the patient transferred to the post-operative care unit.

Measured variables will include systolic, diastolic and mean non-invasive blood pressure, heart rate, number of rescue boluses , incidence of nausea and vomiting (NV), incidence of arrhythmia, Apgar score and fetal cord blood analysis (pH) at delivery.


Recruitment information / eligibility

Status Completed
Enrollment 124
Est. completion date October 1, 2018
Est. primary completion date September 2, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Elective or semi-urgent CD under spinal anesthesia

- Age over 18 years

- Healthy singleton pregnancy beyond 36 weeks' gestation

- American Society of Anesthesiologists (ASA) physical status classification 2

- Weight 50 to 100 kg, and height 150 to 180 cm

Exclusion Criteria:

- Emergency CD red code

- Allergy or hypersensitivity to norepinephrine or sulfite

- Preexisting or pregnancy-induced hypertension, preeclampsia, eclampsia, the use of cardiac medication or medication for blood pressure control

- multiple gestation

- Cardiovascular or cerebrovascular disease

- Fetal abnormalities

- Suspicion of abnormal placentation

- History of diabetes mellitus (excluding gestational diabetes)

- Use of monoamine oxidase inhibitors, triptyline or imipramine antidepressants

- documented history of postoperative nausea and vomiting, previous gastric bypass surgery, history of chronic opioid use (chronic pain syndrome)

- Patient refusal

Study Design


Intervention

Drug:
Norepinephrine: 1mcg/kg
intervention:Parturients will receive Norepinephrine: a bolus of 1 mcg/Kg immediately after SA (preventive bolus) then they will receive complementary doses of Norepinephrine (half dose: 0.5 mcg/Kg) to maintain systolic blood pressure above 80 % of baseline
Norepinephrine 0,5mcg/kg
intervention: Parturients will receive Norepinephrine: a bolus of 0.5 mcg/Kg immediately after SA (preventive bolus) then they will receive complementary doses of Norepinephrine (half dose: 0.25 mcg/Kg) to maintain systolic blood pressure above 80 % of baseline

Locations

Country Name City State
Tunisia Tunis maternity and neonatology center, minisetry of public health Tunis

Sponsors (1)

Lead Sponsor Collaborator
University Tunis El Manar

Country where clinical trial is conducted

Tunisia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to administartion of the first rescue bolus timing of the first hypotension(defined as a decrease of SBP >20% of baseline and/or PAS<100mmHg) recsue bolus will be given at that moment time from immediately after spinal anesthesia until delivery
Primary systolic blood pressure variation difference between the baseline systolic blood pressure (PAS0) and the lowest systolic blood pressure (PASmin) registred before delivery and computed as (PAS min -PAS0)/PAS0 time from immediately after spinal anesthesia until delivery
Primary mean blood pressure variation difference between the baseline mean blood pressure(PAM0) and the lowest mean blood pressure (PAMmin) registred before delivery and computed as (PAM min -PAM0)/PAM0 time from immediately after spinal anesthesia until delivery
Secondary Incidence of hypotension incidence of hypotension after the primary preventive bolus tile from right after spinal anesthesia until delivery
Secondary Norepinephrine consumption Mean dose of Norepinephrine ( micrograms) given to maintain blood pressure between 80 and 100 % of baseline values after the primary preventive bolus time fro right after spinal anesthesia until the end of surgery
Secondary Nausea Incidence of nausea. Measure will be done according to a simple scale: 0= no nausea; 1= nausea [Time time of surgery (right after spinal anesthesia until end of surgery)
Secondary Vomiting incidence of Vomiting (V) during cesarean section with an infusion of a bolus Norepinephrine. Measure will be done according to a simple scale: 0= no vomiting; 1= vomiting time of surgery (right after spinal anesthesia until end of surgery)
Secondary arrhythmia incidence of arrhythmic events during cesarean section with an infusion of a bolus of Norepinephrine time of surgery (right after spinal anesthesia until end of surgery)
Secondary Hypertension a rise of systolic blood pressure (SBP)>20% of baseline or SBP>140mmHg right after spinal anesthesia until end of surgery)]
Secondary mean pH of the fetal cord blood Fetal cord blood analysis will be done immediately after delivery in order to determine the pH value ( ie : logarithm of the blood concentration of hydrogen ions H+)in each group time of birth
Secondary Apgar score apgar at 1 and 5 minutes Apgar at 1 and 5 minutes at time of birth
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04580030 - Tricuapid Annular Plane Sistolic Excursion Before General Anesthesia Can Predict Hypotension After Induction
Active, not recruiting NCT04279054 - Decreased Neuraxial Morphine After Cesarean Delivery Early Phase 1
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Recruiting NCT04099693 - A Prospective Randomized Study of General Anesthesia Versus Anesthetist Administered Sedation for ERCP
Terminated NCT02481999 - Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years
Completed NCT04235894 - An Observer Rating Scale of Facial Expression Can Predict Dreaming in Propofol Anesthesia
Recruiting NCT05525104 - The Effect of DSA on Recovery of Anaesthesia in Children (Het Effect Van DSA op Het Herstel na Anesthesie Bij Kinderen). N/A
Recruiting NCT05024084 - Desflurane and Sevoflurane Minimal Flow Anesthesia on Recovery and Anesthetic Depth Phase 4
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03277872 - NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope N/A
Terminated NCT03940651 - Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase 4
Terminated NCT02529696 - Measuring Sedation in the Intensive Care Unit Using Wireless Accelerometers
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Terminated NCT03704285 - Development of pk/pd Model of Propofol in Patients With Severe Burns
Recruiting NCT05259787 - EP Intravenous Anesthesia in Hysteroscopy Phase 4
Completed NCT02894996 - Does the Response to a Mini-fluid Challenge of 3ml/kg in 2 Minutes Predict Fluid Responsiveness for Pediatric Patient? N/A
Completed NCT05386082 - Anesthesia Core Quality Metrics Consensus Delphi Study
Terminated NCT03567928 - Laryngeal Mask in Upper Gastrointestinal Procedures N/A
Recruiting NCT06074471 - Motor Sparing Supraclavicular Block N/A
Completed NCT04163848 - CARbon Impact of aNesthesic Gas